GenScript Raises HK$2.33 Billion for AIDD Expansion

Evidence Regulatory filing · Discovery September 11, 2026 · Importance 4/5 · Direction Mixed Summary GenScript Biotech conditionally placed 77.126 million new shares at HK$30.50 each, targeting net proceeds of approximately HK$2.327 billion. About 70% is intended for artificial-intelligence-driven drug-discovery capacity and infrastructure, 20% for…